CompoAtlas

Vitapas C

Natural health product licensed in Canada

Other names
Pascorbin
Licence holder
Pascoe Canada
NPN or DIN-HM
80121910
Status
Inactive licence
Licence date
10 November 2022
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine C

Source : Acide ascorbique

333 mg999,000 µg

Non-medicinal ingredients

Hydroxypropyl méthylcellulose, Lécithine, Cellulose

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 6 years ; maximum: 9 years1 Capsule1 day
Adultesminimum: 18 yearsminimum: 1 Capsule ; maximum: 3 Capsule1 day
Adolescentesminimum: 9 years ; maximum: 18 yearsminimum: 1 Capsule ; maximum: 3 Capsule1 day

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps in collagen formation (to maintain/support healthy bones/cartilage/teeth/(and) gums). Helps in wound healing/(and) connective tissue formation. Helps with immune function/the immune system. Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Vitamin supplement.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80121910

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line